Showing 751-760 of 8548 results for "".
Risks of Multiple Primary Melanomas
https://practicaldermatology.com/topics/practice-management/risks-of-multiple-primary-melanomas/21058/Studies offer clarity on risks and patterns after diagnosis, as well as survival outcomes.Inside the Minds of Acne Patients
https://practicaldermatology.com/columns/clinical-focus-1/inside-the-minds-of-acne-patients/23634/Recommendations on how to start developing a treatment plan with its roots in the psychology of the acne patient.Of Fitness, Friction, Fillers, and Fat: Pearls for Managing Active Patients
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/of-fitness-friction-fillers-and-fat-pearls-for-managing-active-patients/23531/Help physically fit patients look as good as they feel.The Financial Contract Every Practice Must Have... And Very Few Do
https://practicaldermatology.com/topics/practice-management/the-financial-every-practice-must-have-and-very-few-do/21166/The Mind-Skin Connection: Psoriasis and Psychological Comorbidities
https://practicaldermatology.com/issues/supplements/the-mind-skin-connection-psoriasis-and-psychological-comorbidities/20833/Mechanism of Action Matters: A Review of New and Emerging Biologics
https://practicaldermatology.com/issues/supplements/mechanism-of-action-matters-a-review-of-new-and-emerging-biologics/23178/Sunscreen Advancements: What to Know
https://practicaldermatology.com/topics/skin-cancer-photoprotection/sunscreen-advancements-what-to-know/23698/New sunscreen formulations are enhancing protection for more patients.Dupilumab For the Management of Pembrolizumab-induced Rash: A Case Report
https://practicaldermatology.com/youngmd-connect/resident-resource-center/dupilumab-for-the-management-of-pembrolizumab-induced-rash-a-case-report/23841/Biosimilar Medicines in Dermatology: Key Aspects
https://practicaldermatology.com/topics/psoriasis/biosimilar-medicines-in-dermatology-key-aspects/22929/After the recent enactment of a specific approval pathway for biosimilars and publication of the first draft guidelines on biosimilar product development by the FDA, biosimilars are expected to be available in the US soon.Incidental Invasive Melanoma Discovered During Excision Of Basal Cell Carcinoma: Implications For The Cutaneous Surgeon
https://practicaldermatology.com/topics/skin-cancer-photoprotection/incidental-invasive-melanoma-discovered-during-excision-of-basal-cell-carcinoma-implications-for-the-cutaneous-surgeon/23981/